Serological investigation for hepatitis E virus infection in the patients with chronic maintenance hemodialysis from southwest of Iran

Asian Journal of Transfusion Science

Volumn 7, Issue 1, 2013, Pages 21-25

  Zekavat, Omid R ^a   Makarem, Alireza ^a   Karami, Mohammad Y ^a   Amanat, Aida ^a   Mohandes, Maesoomeh ^a   Habibagahi, Mojtaba ^b  

^a JAHROM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

ELISA; hemodialysis; Hepatitis E virus; iran; seroprevalence

Indexed keywords

EID: 84879192084     PISSN: 09736247     EISSN: 19983565     Source Type: Journal    
DOI: 10.4103/0973-6247.106724     Document Type: Article

References (37)

1. Yamashita T, Mori Y, Miyazaki N. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci USA 2009;106:129-86.
2. Chandra V, Taneja S, Kalia M, Jameel S, Molecular biology and pathogenesis of hepatitis E virus. J Biosci 2008;33:451-64.
3. Geng J, Wang L, Wang X, Fu H, Bu Q, Liu P, et al. Potential risk of zoonotic transmission from young swine to human: Seroepidemiological and genetic characterization of hepatitis E virus in human and various animals in Beijing, China. J Viral Hepat 2011;18:e583-90.
4. Schlauder GG, Dawson GJ, Mushahwar IK, Ritter A, Sutherland R, Moaness A, et al. Viraemia in Egyptian children with hepatitis E virus infection. Lancet 1993;341:378.
5. Cacciola I, Messineo F, Cacopardo B, Di Marco V, Galli C, Squadrito G, et al. Hepatitis E virus infection as a cause of acute hepatitis in Southern Italy. Dig Liver Dis 2011;43:996-1000.
6. Thomas DL, Mahley RW, Badur S, Palaoglu KE, Quinn TC. Epidemiology of hepatitis E virus infection in Turkey. Lancet 1993;341:1561-2.
7. Pisanti FA, Coppola A, Galli C. Association between hepatitis C and hepatitis E viruses in Southern Italy. Lancet 1994;344:746-7.
8. Arankalle VA, Chobe LP. Retrospective analysis of blood transfusion recipients: Evidence for post-transfusion hepatitis E. Vox Sang 2000;79:72-4.
9. Abe K, Li TC, Ding X, Win KM, Shrestha PK, Quang VX, et al. International collaborative survey on epidemiology of hepatitis E virus in 11 countries. Southeast Asian J Trop Med Public Health 2006;37:90-5.
10. Widdowson MA, Jaspers WJ, van der Poel WH, Verschoor F, de Roda Husman AM, Winter HL, et al. Cluster of cases of acute hepatitis associated with hepatitis E virus infection acquired in the Netherlands. Clin Infect Dis 2003;36:29-33.
11. Herremans M, Vennema H, Bakker J, van der Veer B, Duizer E, Benne CA, et al. Swine-like hepatitis E viruses are a cause of unexplained hepatitis in the Netherlands. J Viral Hepat 2007;14:140-6.
12. Borgen K, Herremans T, Duizer E, Vennema H, Rutjes S, Bosman A, et al. Non-travel related Hepatitis E virus genotype 3 infections in the Netherlands; A case series 2004-2006. BMC Infect Dis 2008;8:61.
13. Hosseini-Moghaddam SM, Zarei A, Alavian SM, Mansouri M. Hepatitis E virus infection: A general review with a focus on hemodialysis and kidney transplant patients. Am J Nephrol 2010;31:398-407.
14. Fabrizi F, Lunghi G, Bacchini G, Corti M, Pagano A, Locatelli F. Hepatitis E virus infection in haemodialysis patients: A seroepidemiological survey. Nephrol Dial Transplant 1997;12:133-6.
15. Ataei B, Nokhodian Z, Javadi AA, Kassaian N, Shoaei P, Farajzadegan Z, et al. Hepatitis E virus in Isfahan Province: A population-based study. Int J Infect Dis 2009;13:67-71.
16. Taremi M, Khoshbaten M, Gachkar L, EhsaniArdakani M, Zali M. Hepatitis E virus infection in hemodialysis patients: A seroepidemiological survey in Iran. BMC Infect Dis 2005;5:36.
17. Taremi M, Mohammad Alizadeh AH, Ardalan A, Ansari S, Zali MR, Seroprevalence of hepatitis E in Nahavand, Islamic Republic of Iran: A population-based study. East Mediterr Health J 2008;14:157-62.
18. Assarehzadegan MA, Shakerinejad G, Amini A, Rezaee SA. Seroprevalence of hepatitis E virus in blood donors in Khuzestan Province, southwest Ira. Int J Infect Dis 2008;12:387-90.
19. Saffar MJ, Farhadi R, Ajami A, Khalilian AR, Babamahmodi F, Saffar H. Seroepidemiology of hepatitis E virus infection in 2-25-year-olds in Sari district, Islamic Republic of Iran. East Mediterr Health J 2009;15:136-42.
20. Eleftheriadis T, Liakopoulos V, Leivaditis K, Antoniadi G, Stefanidis I, Infections in hemodialysis: A concise review. Part II: Blood transmitted viral infections. Hippokratia 2011;15:120-6.
21. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and haemodialysis patients in north Iran-Rasht. J Viral Hepat 2002;9:390-2.
22. Halfon P, Ouzan D, Chanas M, Khiri H, Feryn JM, Mangin L, et al. High prevalence of hepatitis E virus antibody in haemodialysis patients. Lancet 1994;344:746.
23. Buti M, Dominguez A, Plans P, Jardi R, Schaper M, Espunes J, et al. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 2006;13:1328-32.
24. Parana R, Cotrim HP, Cortey-Boennec ML, Trepo C, Lyra L. Prevalence of hepatitis E virus IgG antibodies in patients from a referral unit of liver diseases in Salvador, Bahia, Brazil. Am J Trop Med Hyg 1997;57:60-1.
25. Bayram A, Eksi F, Mehli M, Sozen E. Prevalence of hepatitis E virus antibodies in patients with chronic hepatitis B and chronic hepatitis C. Intervirology 2007;50:281-6.
26. Dalekos GN, Zervou E, Elisaf M, Germanos N, Galanakis E, Bourantas K, et al. Antibodies to hepatitis E virus among several populations in Greece: Increased prevalence in an hemodialysis unit. Transfusion 1998;38:589-95.
27. Mitsui T, Tsukamoto Y, Yamazaki C, Masuko K, Tsuda F, Takahashi M, et al. Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: Evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 2004;74:563-72.
28. Toyoda H, Honda T, Hayashi K, Katano Y, Goto H, Kumada T, et al. Prevalence of hepatitis E virus IgG antibody in Japanese patients with hemophilia. Intervirology 2008;5:121-5.
29. Lee CC, Shih YL, Laio CS, Lin SM, Huang MM, Chen CJ, et al. Prevalence of antibody to hepatitis E virus among haemodialysis patients in Taiwan: Possible infection by blood transfusion. Nephron Clin Pract 2005;99:c122-7.
30. Gerolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008;358:859-60.
31. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: Genetic diversity, subtypes and zoonosis. Rev Med Virol 2006;16:5-36.
32. Husain MM, Aggarwal R, Kumar D, Jameel S, Naik S. Effector T cells immune reactivity among patients with acute hepatitis E. J Viral Hepat 2011;18:e603-8.
33. Turner J, Godkin A, Neville P, Kingham J, Ch'ng CL. Clinical characteristics of hepatitis E in a "Non-Endemic" population. J Med Virol 2010;82:1899-902.
34. Gad YZ, Mousa N, Shams M, Elewa A. Seroprevalence of subclinical HEV infection in asymptomatic, apparently healthy, pregnant women in Dakahlya Governorate, Egypt. Asian J Transfus Sci 2011;5:136-9.
35. Mizuo H, Suzuki K, Takikawa Y, Sugai Y, Tokita H, Akahane Y, et al. Polyphyletic strains of hepatitis E virus are responsible for sporadic cases of acute hepatitis in Japan. J Clin Microbiol 2002;40: 3209-18.
36. Mederacke I, Meier M, Luth JB, Schmidt-Gurtler H, Raupach R, Horn-Wichmann R, et al. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease. Nephrol Dial Transplant 2011;26:2648-56.
37. Bajpai M, Gupta E. Transfusion-transmitted hepatitis E: Is screening warranted? Indian J Med Microbiol 2011;29:353-8.